Novavax, a Maryland-based company that received $1.75 billion from the United States government to develop a protein-based Covid-19 vaccine, announced Monday it had won emergency authorization for its vaccine in Indonesia.After months of production delays, this is the first authorization for Novavax and its manufacturing partner, the Serum Institute of India. They have also applied…
